Will a new vaccine be used?

Journal of human virology Pub Date : 2000-03-01
R G Douglas
{"title":"Will a new vaccine be used?","authors":"R G Douglas","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Despite the fact that vaccines are successful at preventing disease as well as cost-effective, many factors prevent their uptake. These factors are different for different regions. In the United States and Europe, several factors have been identified. The first of these factors is complacency. Both patients and parents lack the knowledge of disease. In addition, physicians are often apathetic about vaccines. There is a lack of training in public health and preventive medicine in that the mind-set of physicians is not directed toward prevention but rather toward treatment. Younger physicians are often less aware of disease controlled by vaccines than their older colleagues are because they have not seen them. One of the paradoxes of vaccines is that success leads to decreased use. Despite the Vaccine for Children's Program, which has provided ample funding for the purchase of vaccines, there are limits on funding for people, facilities, and systematized approaches to maintaining high levels of immunizations. Finally, and perhaps most important, there is fear, real and unfounded. Additionally, in many developing countries there is a lack of focus on preventive medicine, including immunization, as well as limited funding available. Reasonable steps can be taken to overcome these obstacles.</p>","PeriodicalId":80032,"journal":{"name":"Journal of human virology","volume":"3 2","pages":"77-80"},"PeriodicalIF":0.0000,"publicationDate":"2000-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of human virology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Despite the fact that vaccines are successful at preventing disease as well as cost-effective, many factors prevent their uptake. These factors are different for different regions. In the United States and Europe, several factors have been identified. The first of these factors is complacency. Both patients and parents lack the knowledge of disease. In addition, physicians are often apathetic about vaccines. There is a lack of training in public health and preventive medicine in that the mind-set of physicians is not directed toward prevention but rather toward treatment. Younger physicians are often less aware of disease controlled by vaccines than their older colleagues are because they have not seen them. One of the paradoxes of vaccines is that success leads to decreased use. Despite the Vaccine for Children's Program, which has provided ample funding for the purchase of vaccines, there are limits on funding for people, facilities, and systematized approaches to maintaining high levels of immunizations. Finally, and perhaps most important, there is fear, real and unfounded. Additionally, in many developing countries there is a lack of focus on preventive medicine, including immunization, as well as limited funding available. Reasonable steps can be taken to overcome these obstacles.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
会使用新疫苗吗?
尽管疫苗在预防疾病方面取得了成功,而且具有成本效益,但许多因素阻碍了它们的吸收。这些因素在不同地区是不同的。在美国和欧洲,已经确定了几个因素。第一个因素是自满。患者和家长都缺乏疾病知识。此外,医生往往对疫苗漠不关心。缺乏公共卫生和预防医学方面的培训,因为医生的思维方式不是针对预防,而是针对治疗。年轻的医生往往比他们的老同事更不了解疫苗控制的疾病,因为他们没有见过疫苗。疫苗的一个悖论是,成功导致使用减少。尽管“儿童疫苗计划”为购买疫苗提供了充足的资金,但在人员、设施和维持高水平免疫接种的系统化方法方面,资金仍然有限。最后,或许也是最重要的,是恐惧,真实而毫无根据。此外,在许多发展中国家,缺乏对包括免疫接种在内的预防医学的重视,可用资金也有限。可以采取合理的步骤来克服这些障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Associations between MHC class I and susceptibility to HIV-2 disease progression. Positive and negative effects on translation of the hepatitis C virus 3' untranslated region. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments. Abstracts of the 2002 International Meeting of the Institute of Human Virology. September 9-13, 2002, Baltimore, Maryland, USA. The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1